ClinVar Miner

Submissions for variant NM_000038.6(APC):c.1627-1G>A

dbSNP: rs1580573847
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001012475 SCV001172932 pathogenic Hereditary cancer-predisposing syndrome 2019-11-22 criteria provided, single submitter clinical testing The c.1627-1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide upstream from coding exon 13 of the APC gene. RNA studies have demonstrated this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). This alteration has been observed in at least one individual who has a personal or family history that is consistent with APC-associated disease (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on the majority of available evidence to-date, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.